Based on the tumor-supporting roles of EV or of certain EV subpopulations, we hypothesized that EV particle concentrations or levels of PD-L1/2-bearing EV in liquid biopsies of plasma samples may function as useful surrogate markers in TNBC for disease outcome, alone or in combination with distinct CTC subpopulations. The gene discussed is CD274; the disease is neoplasm.